NanoViricides Strengthens its Board of Directors with Addition of Industry Veteran Brian Zucker, CPA
SHELTON, CT / ACCESSWIRE / November 19, 2020 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a leader in developing novel...
SHELTON, CT / ACCESSWIRE / November 19, 2020 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a leader in developing novel...
BEYOND / HELLO Manassas Will Begin Medical Marijuana Dispensary Sales in the Commonwealth of Virginia on Tuesday, December 1, 2021...
MENLO PARK, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
DOYLESTOWN, Pa., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (OTCQB: NPTX), formerly Kannalife, Inc. (the “Company” or "Neuropathix"), a...
- Data support confidence in SPEARHEAD-1 as a registrational trial - - Projected to complete recruitment of all patients in...
VANCOUVER, British Columbia, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (“Pure Extracts” or the “Company”),...
– First Data from Ongoing Phase 2 Study of Controlled IL-12 in Combination with Cemiplimab Demonstrate Promising Safety Profile in...
New Partnership With Leading Dental Support Organization Increases Consumer Choice And Delivers Option To Begin SmileDirectClub Aligner Treatment At Dentists’...
High-throughput clinical assay detects and quantifies SARS-CoV-2 neutralizing antibodies ROCHESTER, Minn., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Imanis Life Sciences,...
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical...
MOUNTAIN VIEW, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D.,...
Strengthens balance sheet with a 50% reduction in 2022 cash obligation and extended term on remaining balance TORONTO, Nov. 19,...
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation...
Weill Cornell Medicine Researchers Utilize Fluidigm Hyperion Imaging System to Identify a Phenotype of Immune Cell Activity Distinct from Other...
$2.5 million upfront for the Ii-Key-H1 vaccine from NuGenerex-Immuno-Oncology (NGIO) and to initiate epitope identification for Ii-Key vaccine development against...
RenovaCare Intellectual Property Update RenovaCare Awarded New Patents for SkinGun™: Ultra-Gentle Cell Spray Technology ROSELAND, N.J., Nov. 19, 2020 (GLOBE...
Upcoming Vaccines Increase the Need for Ongoing Monitoring of Presence and Durability of Immunity Mountain View, CA , Nov. 19,...
Candidate Therapy for Flu+Covid-19 Co-infection Shows Potent Anti-Viral Potential AUSTIN, Texas, Nov. 19, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:...
Capital increase in connection with exercise of warrants Ambu A/S issued 770,000 warrants in 2015, and 419,500 warrants in November...
Advisory Council to collaborate on outreach to retinal clinicians to support development and commercialization of ONS-5010, an investigational ophthalmic formulation...